Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
Related Experiment Video
Updated: Oct 16, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Ashish Sarraju1, Andrew Ward2, Sukyung Chung3
1Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Insights
Electronic health record (EHR)-based machine learning (ML) models significantly improve cardiovascular disease (CVD) risk stratification for secondary prevention. These ML models outperformed traditional risk scores in a multiethnic patient population.
Area of Science:
- Medical Informatics
- Cardiology
- Machine Learning
Background:
- Effective cardiovascular disease (CVD) prevention relies on accurate identification of high-risk patients.
- The utility of electronic health record (EHR)-based machine learning (ML) models for CVD risk stratification compared to traditional scores is not well-established.
Purpose of the Study:
- To compare the performance of EHR-based ML models against the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS 2°P) for CVD risk stratification.
- To evaluate the ability of ML models to predict 5-year CVD event risk in a real-world, multiethnic population.
Main Methods:
- A cohort of 32,192 patients from a large health system was identified, with 80% used for training and 20% for testing ML models.
- Various ML models (Random Forests, Gradient-Boosted Machines, XGBoost, Logistic Regression) were trained using EHR data to predict 5-year CVD event risk.
- Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and compared with TRS 2°P.
Main Results:
- ML models demonstrated good performance, with XGBoost achieving an AUC of 0.70 in the full CVD cohort and 0.71 in the atherosclerotic CVD (ASCVD) cohort.
- The traditional TRS 2°P score performed poorly, with AUCs of 0.51 and 0.50 for CVD and ASCVD patients, respectively.
- ML models identified novel predictive variables, including education level and primary care visit frequency.
Conclusions:
- EHR-based ML models significantly enhance CVD risk stratification for secondary prevention in a real-world, multiethnic setting.
- ML approaches offer a superior alternative to traditional risk scores for identifying high-risk patients for CVD prevention strategies.
Objectives:
Identifying high-risk patients is crucial for effective cardiovascular disease (CVD) prevention. It is not known whether electronic health record (EHR)-based machine-learning (ML) models can improve CVD risk stratification compared with a secondary prevention risk score developed from randomised clinical trials (Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention, TRS 2°P).
Methods:
We identified patients with CVD in a large health system, including atherosclerotic CVD (ASCVD), split into 80% training and 20% test sets. A rich set of EHR patient features was extracted. ML models were trained to estimate 5-year CVD event risk (random forests (RF), gradient-boosted machines (GBM), extreme gradient-boosted models (XGBoost), logistic regression with an L2 penalty and L1 penalty (Lasso)). ML models and TRS 2°P were evaluated by the area under the receiver operating characteristic curve (AUC).
Results:
The cohort included 32 192 patients (median age 74 years, with 46% female, 63% non-Hispanic white and 12% Asian patients and 23 475 patients with ASCVD). There were 4010 events over 5 years of follow-up. ML models demonstrated good overall performance; XGBoost demonstrated AUC 0.70 (95% CI 0.68 to 0.71) in the full CVD cohort and AUC 0.71 (95% CI 0.69 to 0.73) in patients with ASCVD, with comparable performance by GBM, RF and Lasso. TRS 2°P performed poorly in all CVD (AUC 0.51, 95% CI 0.50 to 0.53) and ASCVD (AUC 0.50, 95% CI 0.48 to 0.52) patients. ML identified nontraditional predictive variables including education level and primary care visits.
Conclusions:
In a multiethnic real-world population, EHR-based ML approaches significantly improved CVD risk stratification for secondary prevention.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...